Syneos Health Reports Second Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- US stock futures steady after tech slump; investors focus on Middle East tensions
Syneos (SYNH) PT Raised to $105 at Jefferies
August 10, 2021 8:29 AM EDTJefferies analyst David Windley raised the price target on Syneos (NASDAQ: SYNH) to $105.00 (from $102.00) while maintaining a Buy rating.
The analyst commented, "Bookings highlighted SYNH's 2Q, particularly Clinical with 1.45x b2b for 2Q and 1.37x TTM. Because SYNH's revenue and... More
Syneos Health, Inc. (SYNH) Tops Q2 EPS by 1c, Offers FY Guidance
August 9, 2021 6:14 AM EDTSyneos Health, Inc. (NASDAQ: SYNH) reported Q2 EPS of $0.97, $0.01 better than the analyst estimate of $0.96. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.27 billion.
GUIDANCE:
Syneos Health, Inc. sees FY2021 EPS of $4.25-$4.43, versus the... More
